1 


## **Erase Meso Annual Report period ending 31[st] December 2022** 

## **Registered Charity Number: 1183208** 

**Registered Address: 4 Capern Road, London SW18 3EE** 

## **Trustees During 2020** 

Paul Cook Appointed 1[st] May 2019 Richard Bath Appointed 1[st] May 2019 Wayne O’Neil Appointed 1[st] May 2019 

## **Objectives** 

The objects of Erase Meso (EM) are to promote and protect the physical and mental health of existing and future sufferers of Mesothelioma throughout the world through: 

1. Provision of financial assistance to scientific research aimed at finding a cure for Mesothelioma and/or controlling the non-financial impact of the disease on existing and future sufferers. 

2. Advancement of education and awareness of the general public in all areas relating to Mesothelioma. 

## **Governance** 

EM is a Charitable Incorporated Organisation, established on 1[st] May 2019, and operating according to a Constitution based on the ‘foundation’ model. 

The charity trustees, listed above, make all key decisions and are the only voting members of the Organisation. 

The trustees meet regularly to discuss both operational activities of EM and strategic initiatives and direction. 



2 

## **Events and Activities** 

During 2022 the Trustees initiated the process for establishing a Research Advisory Board to aid with the identification and selection of research projects to fund in line with the EM’s charity’s objectives. 

The establishment of the Advisory Board was in part delayed by the continued disruption from Covid-19, in particular the impact on health professionals and demands on their time. 

Despite the delay, the initiation of the process in 2022 has put the EM in an excellent position to start to fund scientific research into Mesothelioma from 2023 onwards. 

Fundraising events and activities also took place in 2022, albeit on a limited basis due in part to the ongoing impact of Covid-19 and the focus on establishing the Advisory Board.   EM was well supported by the general public and specific donations from generous supporters. 

In addition to the fundraising, we continued to efforts to build partnerships with related charities. 

## **Accounts** 

EM prepare accounts on a receipts and payments basis in line with Charities Commissions requirements. 

For the period 1[st] January 2022 to 31[st] December 2022 funds of £19,024 were raised from events and donations. 

Payments of £1,793 were deducted, relating to liability insurance, IT licences and fees deducted by payment and fundraising platforms.    EM operates on a volunteer basis, and as such no payments were made for management or advisory services during 2022. 

Overall excess of receipts over payments was £17,231, held as part of the cash and equivalents at balance date. 

## **Other** 

The Trustees would like to express our sincere gratitude to all who have supported EM in our endeavour to raise funds for scientific research and to raise awareness of mesothelioma. 

Signed on behalf of the Trustees 

Paul Cook (Trustee) 

Richard Bath (Trustee) 



||**Charity Name**<br> <br>**Oaks Meadow Project**|**Charity Name**<br> <br>**Oaks Meadow Project**|**Charity Name**<br> <br>**Oaks Meadow Project**|**No (if any)**|**CC16a**|
|---|---|---|---|---|---|
||**For the period**<br>**from**|Period start date<br>01.04.22|**To**|Period end date<br>31.03.23||
|||||||
|**Section A Receipts and payments**||||||
|**A1 Receipts**<br>Donations<br>**38**<br>Mid Suffolk District Council<br>**-**<br>Councillor LocalityBudgets<br>**-**<br>Combs Parish Council<br>**-**<br>Valencia Communities Fund<br>**-**<br>Local Fund Raising<br>**312**<br>**-**<br>**-**<br>**350**<br>**-**<br>**-**<br>**_Sub total_                              -**<br>**_Total receipts_                      350**<br>**A3 Payments**<br>Insurance<br>Bank Charges<br>**-**<br>Site,Groundworks & Desogm<br>**-**<br>Admin & Office<br>**-**<br>Cost of Events<br>**188**<br>**-**<br>**-**<br>**-**<br>**-**<br>**_Sub total_                          188**<br>**Structures & Equipment**<br>Playground Fixtures & Fittings<br>**-**<br>**_Sub total_                               -**<br>**_Total payments_                      188**<br>**_Net of receipts/(payments)_                      162**<br>**A5 Transfers between funds**<br>**-**<br>**A6 Cash funds last year end**<br>**-**<br>**_Cash funds this year end_                      162**<br>**Unrestricted**<br>**funds**<br>**to the nearest      £**<br>**_Sub total_**_(Gross income for AR)_<br>**A2 Asset and investment sales,**<br>**(see table).**<br>**A4 Asset and investment**<br>**purchases, (see table)**||**to the nearest £**<br>**-**<br>**25,000**<br>**1,502**<br>**865**<br>**50,000**<br>**-**<br>**-**<br>**-**<br>**77,367**<br>**-**<br>**-**<br>**-**<br>**77,367**<br>**146**<br>**72**<br>**20,092**<br>**218**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**20,528**<br>**1,062**<br>**63,553**<br>**64,615**<br>**85,143**<br>**-                 7,776**<br>**-**<br>**-**<br>**-                 7,776**<br>**Restricted**<br>**funds**|**to the nearest £**<br>**Endowment**<br>**funds**|**Total funds**<br>**to the nearest £**<br>**38**<br>**25,000**<br>**1,502**<br>**865**<br>**50,000**<br>**312**<br>**-**<br>**-**<br>**77,717**<br>**-**<br>**-**<br>**-**<br>**77,717**<br>**146**<br>**72**<br>**20,092**<br>**218**<br>**188**<br>**-**<br>**-**<br>**-**<br>**-**<br>**20,716**<br>**1,062**<br>**63,553**<br>**64,615**<br>**85,331**<br>**-                 7,614**<br>**-**<br>**-**<br>**-                 7,614**|**Last year**<br>**to the nearest £**|
||||**-**|**38**|**-**|
||||**-**|**25,000**|**-**|
||||**-**|**1,502**|**-**|
||||**-**|**865**|**-**|
||||**-**|**50,000**|**-**|
||||**-**|**312**|**-**|
||||**-**|**-**|**-**|
||||**-**|**-**|**-**|
||||**-**|**77,717**|**-**|
|||||||
||||**-**|**-**||
||||**-**|**-**|**-**|
||||**-**|**-**|**-**|
|||||||
||||**-**|**77,717**|**-**|
|||||||
||||**-**|**146**|**-**|
||||**-**|**72**|**-**|
||||**-**|**20,092**|**-**|
||||**-**|**218**|**-**|
||||**-**|**188**|**-**|
||||**-**|**-**|**-**|
||||**-**|**-**|**-**|
||||**-**|**-**|**-**|
||||**-**|**-**|**-**|
||||**-**|**20,716**|**-**|
|||||||
||||**-**|**1,062**||
||||**-**|**63,553**||
||||**-**|**64,615**|**-**|
|||||||
||||**-**|**85,331**|**-**|
|||||||
|||**-                 7,776**|**-**|**-                 7,614**|**-**|
|||**-**|**-**|**-**|**-**|
|||**-**|**-**|**-**|**-**|
|||**-                 7,776**|**-**|**-                 7,614**|**14,766**|





## **Section B Statement of assets and liabilities at the end of the period** 

|**Categories**<br>**B1 Cash funds**<br>**B2 Other monetary assets**<br>**B3 Investment assets**<br>**B5 Liabilities**<br>**B4 Assets retained for the**<br>**charity’s own use**|**Details**<br>Bank Balance<br>Cash in Hand<br>**Details**<br>**Details**<br>**Details**<br>**Details**<br>**_Total cash funds_**<br>(agree balances with receipts and payments<br>account(s))|**to nearest £**<br>**7,138**<br>**14**<br>**-**<br>**7,152**<br>Agreement Error<br>**to nearest £**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**Unrestricted**<br>**funds**<br>**Unrestricted**<br>**funds**<br>**Fund to which**<br>**asset belongs**<br>**Fund to which**<br>**asset belongs**<br>**Fund to which**<br>**liability relates**|**to nearest £**<br>**-**<br>**-**<br>**-**<br>**-**<br>Agreement Error<br>**to nearest £**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**Cost (optional)**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**Cost (optional)**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**Restricted**<br>**funds**<br>**Restricted**<br>**funds**<br>**Amount due**<br>**(optional)**|**to nearest £**<br>**Endowment**<br>**funds**|
|---|---|---|---|---|
|||||**-**|
|||||**-**|
|||||**-**|
|||||**-**|
|||||OK|
|||||**to nearest £**<br>**Endowment**<br>**funds**|
|||||**-**|
|||||**-**|
|||||**-**|
|||||**-**|
|||||**-**|
|||||**-**|
|||||**Current value**<br>**(optional)**|
|||||**-**|
|||||**-**|
|||||**-**|
|||||**-**|
|||||**-**|
|||||**Current value**<br>**(optional)**|
|||||**-**|
|||||**-**|
|||||**-**|
|||||**-**|
|||||**-**|
|||||**-**|
|||||**-**|
|||||**-**|
|||||**-**|
|||||**When due**<br>**(optional)**|
||||**-**||
||||**-**||
||||**-**||
||||**-**||
||||**-**||



Signed by one or two trustees on behalf of all the trustees 

Signature 

Print Name 

Date of approval 

